MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0267037
Siro Clinpharm Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.18 Cr
▲ 13% YoY
Net profit · FY 2025
₹12.26 Cr
Net margin 30.5%
EBITDA · FY 2025
₹16.75 Cr
EBITDA margin 41.7%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹6.1 Lakh
Issued & subscribed
Open charges
₹5.16 Cr
Satisfied ₹119.93 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
258
Provident fund records
About Siro Clinpharm Private Limited
Data last updated:
Siro Clinpharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2000 and has been in existence for over 26 years.
Its director Gautam Daftary and family are #1,009 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2000PTC125061. Its GSTIN is 27AAECS8588A1Z3 (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹6.1 Lakh. It is led by directors including Karan Gautam Daftary (Whole-Time Director) and Akshay Gautam Daftary.
Its last annual general meeting (AGM) was held on 31 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 16th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.18 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹12.26 Cr (net margin 30.5%) and EBITDA of ₹16.75 Cr (EBITDA margin 41.7%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 8% over five years.
The company has about 258 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Siro Clinpharm. As per MCA filings, the company has open charges of ₹5.16 Cr and satisfied charges of ₹119.93 Cr on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it; 2 cases are pending. The company has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022. The company has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier.
Siro Clinpharm Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0267037). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website siroclinpharm.com.
Company details
CIN U24230MH2000PTC125061
Registration Number 125061
Incorporation Date 21 March 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0267037
Key People
Karan Gautam Daftary Whole-Time Director Akshay Gautam Daftary Director Gautam Vinod Daftary Director Recognitions & Rankings of Siro Clinpharm
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,009 Gautam Daftary & family ₹2,700 Cr
Contact details
Siro Clinpharm Private Limited's registered office is in Mumbai, Maharashtra. Its website is siroclinpharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address16th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Siro Clinpharm Private Limited, buy the company report.
Comprehensive company report
Siro Clinpharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Siro Clinpharm operates one associated brand: Siro Clinpharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical development services are offered to the global healthcare industry. | siroclinpharm.com |
Financials of Siro Clinpharm Private Limited
FY 2024 filings availableSiro Clinpharm Private Limited reported revenue of ₹40.18 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹40.18 Cr ▲ 13%
Net profit · FY 2025
₹12.26 Cr margin 30.5%
EBITDA · FY 2025
₹16.75 Cr margin 41.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 16%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 5%
5 years · compounded
▲ 18%
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.7% | ||||
| Net Profit Margin | 30.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Siro Clinpharm Private Limited, buy the company report.
Board of directors of Siro Clinpharm Private Limited
Siro Clinpharm has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Gautam Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Aksitech Life Sciences Private Limited and 5 more | Director | 12 Feb 2018 | 8 Years 8 Months | Current |
| Karan Gautam Daftary Also directs: Iravata Retail Enterprises LLP, Ceresity Technologies Private Limited, Siro Medical Writing Private Limited and 5 more | Whole-Time Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Gautam Vinod Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Hitech Laboratories Private Limited and 5 more | Director | 21 Mar 2000 | 26 Years 7 Months | Current |
Auditor
Siro Clinpharm Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2022 | 117366W/W-100018 |
Shareholding
The shareholding of Siro Clinpharm Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Siro Clinpharm Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.16 Cr
Satisfied charges
₹119.93 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2024 | 101035220 | Others | ₹1.5 Cr | Open | |
| 16 Oct 2024 | 100995543 | Others | ₹1.29 Cr | Open | |
| 27 Mar 2024 | 100910202 | Others | ₹1.37 Cr | Open | |
| 24 Nov 2021 | 100517853 | Others | ₹1 Cr | Open | |
| 12 Mar 2019 | 100247781 | Others | ₹4.5 Cr | Satisfied |
To see the full charge records of Siro Clinpharm Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Siro Clinpharm Private Limited has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022.
Total deals
12
Secondary share transfers
9
Funding rounds
2
Rights issue
1
Disclosed funding
₹22.5 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: KOTAK SECURITIES LIMITED |
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Kotak Private Equity, 3 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jan 2014 | Rights issue | ₹10,000 | Investors: 2 individuals |
To see the full deal history of Siro Clinpharm Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Siro Clinpharm Private Limited has 14 court cases on record: 2 filed by Siro Clinpharm, 12 filed against it. 2 cases are pending and 12 are disposed.
Total cases
14
Filed by the company
2
Filed against the company
12
Pending
2
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 11 | 2 |
| District courts | 2 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by The PR. Commissioner of Income Tax- 3 Mumbai | Pending |
| Bombay High Court | Tax appeal | Filed against the company by The PR. Commissioner of Income Tax-3 | Pending |
| NCLT, Mumbai | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Service Tax Mumbai VIII Commissionerate | Disposed |
| Bombay High Court | Court case (CHOL) | Filed against the company by The Commissioner of Service Tax Mumbai VIII Commissionerate | Disposed |
To see the full case history of Siro Clinpharm Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Siro Clinpharm Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sevenstar Facility India Private Limited |
To see the full MSME payment records of Siro Clinpharm Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Siro Clinpharm Private Limited has a workforce of 258 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
258
Active EPFO establishments
1
Employee growth
-1.53%
GST
Siro Clinpharm has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECS8588A1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 36AAECS8588A1Z4 | Telangana | Active | 28 Jul 2018 |
To see the full GST registrations and return filing status of Siro Clinpharm Private Limited, buy the company report.
Recent activity
Siro Clinpharm Private Limited has 18 board changes on record since 2000: 3 appointments and 15 cessations. The latest: Akshay Gautam Daftary ceased to be Additional Director on 30 Jul 2022.
AGM
Siro Clinpharm Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101035220 was registered on 30 Dec 2024.
Charges
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 100995543 was registered on 16 Oct 2024.
Filing
Siro Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100910202 was registered on 27 Mar 2024.
Ceased
Akshay Gautam Daftary ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100517853 was registered on 24 Nov 2021.
Charges
A charge registered on 26 Oct 2017 via Charge ID 100159408 with Others was fully satisfied on 08 Nov 2021.
Charges
A charge registered on 12 Mar 2019 via Charge ID 100247782 with Others was fully satisfied on 18 May 2021.
Charges
A charge registered on 12 Mar 2019 via Charge ID 100247781 with Others was fully satisfied on 16 Apr 2021.
Charges
A charge registered on 29 Jan 2014 via Charge ID 10475628 with Others was fully satisfied on 28 Mar 2019.
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100247781 was registered on 12 Mar 2019.
42 earlier events are in the company report.
News
Frequently asked questions
Siro Clinpharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2000 (26+ years old) and is registered under CIN U24230MH2000PTC125061.
Siro Clinpharm has 3 current directors:
- Karan Gautam Daftary - Whole-Time Director
- Akshay Gautam Daftary - Director
- Gautam Vinod Daftary - Director
The latest financial statements of Siro Clinpharm on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 December 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Siro Clinpharm is 27AAECS8588A1Z3, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAECS8588A1Z4 (Telangana).
The CIN (Corporate Identification Number) of Siro Clinpharm is U24230MH2000PTC125061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siro Clinpharm has 14 court cases on record: 2 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.
Siro Clinpharm was incorporated on 21 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Siro Clinpharm has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022.
Akshay Gautam Daftary ceased to be Additional Director on 30 Jul 2022. Sanjay Chandrasen Rane ceased to be Company Secretary on 31 Jan 2019. Karan Gautam Daftary was appointed as Whole-Time Director on 12 Sep 2018. Siro Clinpharm has 18 board changes on record in total.
Yes, Siro Clinpharm is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0267037).
Siro Clinpharm has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 16 Dec 2020.